biomedicina slovenica


angiogenic : 57

  1. Kimáková Patrícia; Solár Peter; Solárová Zuzana; Komel Radovan; Debeljak Nataša
    Erythropoietin and its angiogenic activity
    2017
  2. Bošnjak Maša; Dolinšek Tanja; Čemažar Maja; Kranjc Simona; Blagus Tanja; Markelc Boštjan; Štimac Monika; Završnik Janja; Kamenšek Urška; Heller Loree C.; Bouquet Céline; Turk Boris; Serša Gregor
    Gene electrotransfer of plasmid AMEP, an integrin-targeted therapy, has antitumor and antiangiogenic action in murine B16 melanoma
    2015
  3. Kamenšek Urška; Tešić Nataša; Serša Gregor; Čemažar Maja
    Constructing clinically applicable antibiotic-free plasmids for gene electrotransfer mediated immuno and antiangiogenic therapy of cancer
    2015
  4. Čemažar Maja; Dolinšek Tanja; Tešić Nataša; Štimac Monika; Serša Gregor
    Electrotransfer of antiangiogenic shRNA agains endoglin for effective cancer treatment
    2015
  5. Dolinšek Tanja; Markelc Boštjan; Bošnjak Maša; Blagus Tanja; Prosen Lara; Kranjc Simona; Štimac Monika; Lampreht Urša; Serša Gregor; Čemažar Maja
    Endoglin silencing has significant antitumor effect on murine mammary adenocarcinoma mediated by vascular targeted effect
    2015
  6. Škrgat-Kristan Sabina
    Blood specimen biomarkers of inflammation, matrix degradation, angiogenesis, and cardiac involvement
    2013
  7. Štimac Monika; Dolinšek Tanja; Lampreht Urša; Čemažar Maja; Serša Gregor
    Gene electrotransfer of plasmid with tissue specific promoter encoding shRNA against endoglin exerts antitumor efficacy against murine TS/A tumors by vascular targeted effects
    2015
  8. Katuchova Jana; Harvanova Denisa; Spakova Timea; Kalanin Rastislav; Farkas Daniel; Durny Peter; Rosocha Jan; Radonak Jozef; Petrovič Danijel; Siniscalco Dario
    Mesenchymal stem cells in the treatment of type 1 Diabetes mellitus
    2015
  9. Delić Ratko; Štefanović Mario; Krivec Štefka; Weber Vladimir
    Statistical regression model of standard and new laboratory markers and its usefulness in prediction of preeclampsia
    2014
  10. Vrtačnik-Bokal Eda; Osredkar Joško; Babič Katica; Bačer-Kermavner Liljana
    GnRH agonists vs. GnRH antagonists regarding the follicular angiogenic substances in women with polycystic ovarian syndrome
    2006
  11. Ocvirk Janja
    Anti-angiogenic therapy for malignant gliomas
    2009
  12. Bošnjak Maša; Prosen Lara; Dolinšek Tanja; Blagus Tanja; Markelc Boštjan; Čemažar Maja; Bouquet Céline; Serša Gregor
    Biological properties of melanoma and endothelial cells after plasmid AMEP gene electrotransfer depend on integrin quantity on cells
    2013
  13. Prosen Lara; Markelc Boštjan; Dolinšek Tanja; Mušič Branka; Čemažar Maja; Serša Gregor
    Mcam silencing with RNA interference using magnetofection or gene electrotransfer has antitumor and antiangiogenic effect
    2014
  14. Prosen Lara; Markelc Boštjan; Dolinšek Tanja; Mušič Branka; Čemažar Maja; Serša Gregor
    Mcam silencing with RNA interference using magnetofection has antitumor effect in murine melanoma
    2014
  15. Mesti Tanja; Savarin Philippe; Triba Mohamed N.; Ocvirk Janja; Banissi Claire; Carpentier Antoine F.
    Metabolic impact of anti-angiogenic agents on glioma cells
    2014
  16. Carpentier Antoine F.; Mesti Tanja; Banissi Claire; Savarin Philippe; Triba Mohamed N.; Ocvirk Janja
    Metabolic profiling of antiangiogenic agents on glioma cells
    2014
  17. Mesti Tanja; Savarin Philippe; Triba Mohamed N.; Le Moyec Laurence; Ocvirk Tanja; Banissi Claire; Carpentier Antoine F.
    Metabolic impact of anti-angiogenic agents on U87 glioma cells
    2014
  18. Dolinšek Tanja; Čemažar Maja
    Antiangiogeni in protitumorski učinek genske terapije s kratkimi nekodirajočimi molekulami RNA proti endoglinu na mišjih tumorskih modelih
    [Antiangiogenic and antitumor effect of gene therapy with short noncoding RNA molecules against endoglin in murine tumor models]
    2014
  19. Liu G.; Jeraj Robert; Vanderhoek M.; Perlman S. B.; Kolesar Jill M.; Harrison M.R.; Simončič Urban; Eickhoff J.C.; Carmichael L.; Chao B.; Marnocha R.; Ivy P.; Wilding G.
    Pharmacodynamic Study Using FLT PET/CT in Patients with Renal Cell Cancer and Other Solid Malignancies Treated with Sunitinib Malate
    2011
  20. Spanggaard Iben; Snoj Marko; Cavalcanti Andrea; Bouquet Céline; Serša Gregor; Robert Caroline; Čemažar Maja; Dam Elisabeth; Vasseur Bérangère; Attali Pierre; Mir Lluis Maria; Gehl Julie
    Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma
    2013
  21. Bulgin Dmitry; Vrabič Erik; Hodzic Enes
    Autologous bone-marrow-derived-mononuclear-cells-enriched fat transplantation in breast augmentation
    2013
  22. Vrtovec Bojan; Poglajen Gregor; Sever Matjaž; Ležaič Luka; Sočan Aljaž; Haddad F.; Wu JC
    CD34(+) stem cell therapy in nonischemic dilated cardiomyopathy patients
    2013
  23. Wu Guifu; Mannam Arjuna P.; Wu Jiaping; Kirbiš Simona; Shie Jue-Lon; Chen Christopher; Laham Roger J.; Sellke Frank W.; Li Jian
    Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF
    2003
  24. Serša G
    Translational studies of immunomodulatory and antiangiogenic gene therapy
    2012
  25. Rozman Aleš; Šilar Mira; Košnik Mitja
    Angiogenin and vascular endothelial growth factor expression in lungs of lung cancer patients
    2012
  26. Jusufović Edin; Rijavec Matija; Keser Dragan; Korošec Peter; Sodja Eva; Iljazović Ermina; Radojević Zorica; Košnik Mitja
    Iet-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non-small-cell lung cancer
    2012
  27. Howl John; Matou-Nasri Sabine; West David C; Zorko Matjaž
    Bioportide: an emergent concept of bioactive cell-penetrating peptides
    2012
  28. Kristan SS; Marc MM; Kern I; Fležar M; Šuškovič S; Košnik M; Korošec P
    Airway angiogenesis in stable and exacerbated chronic obstructive pulmonary disease
    2012
  29. Jusufović Edin; Rijavec Matija; Keser Dragan; Sodja Eva; Košnik Mitja; Korošec Peter
    Anti-angiogenic miRNA let-7b and miR-126 are down-regulated in tumor and tumor surrounding in NSCLC lung tissue
    2011
  30. Cilenšek Ines; Hercegovac Amela; Nikolajević-Starčević Jovana; Vukojević Katarina; Saraga-Babić Mirna; Milutinović-Živin Aleksandra
    Polymorphisms of interleukin-4, -10 and 12B genes and diabetic retinopathy
    2011
  31. Rajčević Uroš; Petersen Kjell; Knol Jaco C; Loos Maarten; Bougnaud Sebastian; Miletic Hrvoje; Wang Jian; Bjerkvig Rolf; Jimenez Connie R; Niclou Simone P
    Molecular variations in tumor-host interactions between invasive and angiogenic phenotype in high-grade gliomas
    2009
  32. Ćirić Eva; Serša Gregor
    Radiotherapy in combination with vascular-targeted therapies
    [Radioterapija v kombinaciji z zdravili usmerjenimi proti tumorskemu žilju]
    2010
  33. Petrovič D
    The role of vascular endothelial growth factor gene as the genetic marker of atherothrombotic disorders and in the gene therapy of coronary artery disease
    2010
  34. Rajčević Uroš; Bougnaud Sebastien
    iTRAQ based proteomic profiling reveals increased metabolic activity and cellular crosstalk in angiogenic compared to invasive glioblastoma phenotype
    2009
  35. Legan Mateja; Luzar Boštjan; Ferlan-Marolt Vera
    Expression of cyclooxygenase-2, glucose transporter-1 and angiogenesis in gallbladder carcinomas and their impact on prognosis
    2009
  36. Slabe Nina; Košir Renata; Meden-Vrtovec Helena
    Sodobni pogled na etiopatogenezo endometrioze
    [Contemporary view on ethiopathogenesis of endometriosis]
    2009
  37. Rajčević Uroš; Knol Jaco C; Loos Maarten; Li KaWan; Klychnikobv Oleg; Bjerkvig Rolf; Petersen Kjell; Pham Thang V; Jimenez Connie R; Niclou Simone P
    Addressing the angiogenic switch by studying tumor-host interactions in a model of glioma
    2008
  38. Rajčević Uroš; Niclou Simone P; Jimenez Connie R
    Proteomics strategies for target identification and biomarker discovery in cancer
    2009
  39. Rajčević Uroš; Knol Jaco C; Loos Maarten; Enger Per Oyvind; Wang Jian; Bjerkvig Rolf; Petersen Kjell; Jimenez Connie R; Niclou Simone P
    Addressing the angiogenic switch by studying tumor-host interactions in an animal model of glioblastoma multiforme
    2008
  40. Rajčević Uroš; Knol Jaco C; Loos Maarten; Petersen Kjell; Bjerkvig Rolf; Jimenez Connie R; Niclou Simone P
    Addressing the Angiogenic Switch by Studying Tumor-Host Interactions in an Animal Model of Glioblastoma Multiforme
    2008
  41. Kristan SS; Malovrh MM; Šilar M; Kern I; Fležar M; Košnik M; Šuškovič S; Korošec P
    Airway angiogenesis in patients with rhinitis and controlled asthma
    2009
  42. Globočnik-Petrovič Mojca; Osredkar Joško; Saraga-Babić Mirna; Petrović Daniel
    K469E polymorphism of the intracellular adhesion molecule I gene is associated with proliferative diabetic retinopathy in caucasians with type 2 diabetes
    2008
  43. Škrgat-Kristan S
    Angiogenic factors in the lungs of patients with chronic obstructive pulmonary disease
    2008
  44. Hojs Nina; Hrovat Eva
    Vasa vasorum in ateroskleroza koronarnih arterij
    [Vasa Vasorum and atherosclerosis of coronary arteries]
    2008
  45. Globočnik-Petrovič Mojca; Korošec Peter; Košnik Mitja; Osredkar Joško; Hawlina Marko; Peterlin Borut; Petrovič Danijel
    Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy
    2008
  46. Pavlin Darja; Tozon Nataša; Serša Gregor; Pogačnik Azra; Čemažar Maja
    Electrogene therapy in cancer treatment
    [Elektrogenska terapija pri zdravljenju raka]
    2006
  47. Blinc Aleš
    Angiogeneza - terapevtska tarča pri zdravljenju raka in arterijske okluzivne bolezni
    2006
  48. Legan Mateja
    New marker of angiogenesis CD105 (endoglin): diagnostic, prognostic and therapeutic role
    [Novi označevalec angiogeneze CD105 (endoglin): diagnostični, napovedni in terapevtski pomen]
    2005
  49. Blacher Silvia; Devy Laetitia; Hlushchuk Ruslan; Larger Etienne; Lamande Noel; Burri Peter; Corvol Pierre; Djonov Valentin; Foidart Jean-Michael; Noeol Agnes
    Quantification of angiogenesis in the chicken chorioallantoic membrane (CAM)
    2005
  50. Glaser Marjana
    Plazmocitom - diferencialna diagnoza in zdravljenje
    [Multiple myeloma - differential diagnosis and therapy]
    2005
  51. Vrtačnik-Bokal E; Meden-Vrtovec H; Virant-Klun I; Verdenik I
    Prolonged HCG action affects angiogenic substances and improves follicular maturation, oocyte quality and fertilization competence in patients with polycystic ovarian syndrome
    2005
  52. Caserman Simon
    Vloga proteoliznih encimov pri invazivni rasti endotelijskih celic med procesom angiogeneze
    2004
  53. Modic Mojca; Kralj Jana; Čibej Lara; Mlakar Uroš
    Koncentracije nekaterih dejavnikov angiogeneze v serumu pri diseminiranem plazmocitomu: VEGF, bFGF in MMP-9
    [Serum concentrations of some angiogeneic factors in multiple myeloma: VEGF, bFGF in MMP-9]
    2004
  54. Štabuc Borut
    Sistemsko zdravljenje raka trebušne slinavke
    [Chemotherapy for pancreatic cancer]
    2002
  55. Rajčević Uroš
    Ugotavljanje ravni izražanja onkogenov pri raku želodca s fluorescenčnim označevanjem in sočasnim pomnoževanjem genskih prepisov
    2002
  56. Bruenner Nils
    In vitro and in vivo angiogenic assays
    2002
  57. Videčnik Viktor; Kozak Matija; Blinc Aleš
    Terapevtska angiogeneza
    [Therapeutic angiogenesis]
    1999


Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko